Business Standard

India's nasal vaccine not for those who have taken booster: NTAGI chairman

The Indian nasal vaccine cannot be given to those who have allready taken a precaution or booster dose, the head of the country's vaccine task force said

Bharat Biotech’s iNCOVACC, Bharat Bio’s nasal Covid vaccine, nasal Covid vaccine, Covid vaccine
Premium

Bharat Bio’s nasal Covid vaccine

BS Web Team New Delhi
India's nasal vaccine cannot be given to those who have already taken a precaution or booster dose, the head of the country's vaccine task force said, according to a report by NDTV.

The nasal vaccine iNCOVACC was introduced on the CoWIN platform last week. 

The nasal vaccine is to be used as the "first booster" according to Dr NK Arora, the Chairman of the Covid Working Group of National Technical Advisory Group on Immunisation (NTAGI).

NTAGI works on introducing new vaccines and strengthening the universal immunisation programe in India.

Asserting that CoWIN will not accept a fourth dose, Dr Arora

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in